Trials / Conditions / Community Acquired Bacterial Pneumonia

Community Acquired Bacterial Pneumonia

12 registered clinical trials studyying Community Acquired Bacterial Pneumonia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to NCT06162286	Zai Lab (Hong Kong), Ltd.	Phase 3
Completed	Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pn NCT02679573	Melinta Therapeutics, Inc.	Phase 3
Terminated	Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia NCT02605122	Melinta Therapeutics, Inc.	Phase 2 / Phase 3
Completed	Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxif NCT01968733	Melinta Therapeutics, Inc.	Phase 3
Completed	Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patien NCT01756339	Melinta Therapeutics, Inc.	Phase 3
Completed	Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia NCT01605864	Albany Medical College	Phase 3
Completed	A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the T NCT01371838	Pfizer	Phase 3
Withdrawn	Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired NCT00914888	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Withdrawn	Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired NCT01602874	Pfizer	Phase 3
Completed	Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Communit NCT01168713	Melinta Therapeutics, Inc.	Phase 2
Completed	Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment NCT01072539	Pfizer	—
Completed	Study of Fluid Collection of the Chest in Children With Pneumonia NCT00202826	Corewell Health West	Phase 3